Sign Up to like & get
recommendations!
0
Published in 2022 at "Oncology"
DOI: 10.1159/000525742
Abstract: Introduction: This retrospective study investigated the efficacy and safety of nano-liposomal irinotecan (nal-IRI) plus 5-fluorouracil/L-leucovorin (5-FU/l-LV) treatment in the second-line or later setting for advanced pancreatic cancer under real-world conditions. Methods: Between June 2020 and…
read more here.
Keywords:
pancreatic cancer;
advanced pancreatic;
unresectable advanced;
efficacy safety ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Journal of Thoracic Disease"
DOI: 10.21037/jtd-22-704
Abstract: Background Patients with initially unresectable advanced non-small cell lung cancer (NSCLC) might experience prolonged responses under immune checkpoint inhibitors (ICIs). In this setting, Multidisciplinary Tumor Board (MTB) seldomly suggest surgical resection of the primary tumor…
read more here.
Keywords:
non small;
initially unresectable;
lung;
unresectable advanced ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "In Vivo"
DOI: 10.21873/invivo.12112
Abstract: Aim: To determine whether markers of systemic inflammatory response and nutrition are a predictor of treatment response in patients with trastuzumab-treated unresectable advanced gastric cancer. Patients and Methods: Twenty-one patients who received chemotherapy for unresectable…
read more here.
Keywords:
response;
gastric cancer;
inflammatory response;
cancer ... See more keywords